Organization of the Institute

Organization of the Institute

 

Administration

Administration

The administration at the Max Planck Institute of Biochemistry supports the scientists by providing all necessary administrative and technical services in the areas of personnel management, financial accounting and purchasing. The services also include an externally operated canteen, a guest house as well as a transport service, a nursery and a laundry service. Apprentices are also trained in the administration department. The aim is to support and relieve the scientific departments and research groups.

Executive Management

Executive Management

According to the statutes, the scientific and administrative management of the Max Planck Institute of Biochemistry (MPIB) is the responsibility of the Directors. They are Scientific Members of the Max Planck Gesellschaft (MPG) and at the same time Research Directors of the MPIB appointed by the Senate of the Max Planck Gesellschaft. The MPIB Managing Board (Geschäftsführende Leitung, GL) consists of a Managing Director, who is appointed by the President of the MPG, and two deputies. The GL is responsible for the daily business at the Institute and implements the decisions taken by the Board of Directors. It is supported by the Office of the Managing Board (GL office) as well as by the administration.

Scientific Advisory Board

Scientific Advisory Board


In order to guarantee the high quality and productivity of research at the institutes in the long term, all Max Planck Institutes are regularly reviewed by independent scientific advisory boards. All members of the MPIB Scientific Advisory Board are not members of the Max Planck Society (MPG) and are mostly from abroad. The members are appointed by the President of the MPG. They regularly assess the quality of the research work, the success in acquiring third-party funding, the cooperation activities with other research projects and other quality-relevant criteria.

Members of MPIB's Scientific Advisory Board:

Prof. Dr. Wendy Bickmore, The University of Edinburgh, UK
Link MRC Human Genetics Unit

Prof. Elizabeth Campbell, PhD The Rockefeller University, New York, USA
Link Laboratory of Molecular Biophysics

Prof. Jyoti Choudhary, PhD The Institute of Cancer Research, London, UK
Link The Institute of Cancer Research

Prof. Dr. Anita Corbett, Emory University, Atlanta, USA
Link Emory College of Arts and Sciences

Prof. Vishva Dixit, M.D., Genentech Inc., South San Francisco, USA
Link Physiological Chemistry Department

Prof. Dr. Lila Gierasch, University of Massachusetts, Amherst, USA
Link Life Science Laboratories N331

Prof. Dr. Kay Grünewald, CSSB - Centre for Structural Systems Biology, Hamburg, Germany
Link CSSB

Prof. Katrin Karbstein, PhD , Vanderbilt University, Nashville, TN, USA
Link The Karbstein LAB

Prof. Scott Keeney, PhD, Memorial Sloan Kettering Cancer Center, New York, USA
Link Memorial Sloan Kettering Cancer Center

Prof. Dr. Karolin Luger, University of Colorado Boulder, Boulder, USA
Link Luger Lab, JSCBB

Prof. Dr. Emma Lundberg, KTH Royal Institute of Technology, Stockholm, Sweden
Link SciLifeLab

Prof. Dr. Gioacchino Natoli, Istituto Europeo di Oncologia, Milano, Italy
Link Transcriptional Control in Inflammation and Cancer

Prof. Eva Nogales, PhD, HHMI/ University of California, Berkeley, USA
Link TheNogalesLab

Prof. Dr. med. Klaus Pantel, Universitätsklinikum Hamburg-Eppendorf (UKE), Hamburg, Germany
Link Scientist Klaus Pantel

Prof. Dr. med. Nikolaus Pfanner, University of Freiburg, Freiburg, Germany
Link Institute of Biochemistry and Molecular Biology

Prof. Dr. Manuel Théry, CytoMorpho Lab at Hôpital Saint-Louis, Paris, France
Link cytomorpholab

Prof. Johannes Walter, PhD, Howard Hughes Medical Institute, Boston, USA
Link WalterLab

Prof. Cynthia Wolberger, PhD, Johns Hopkins School of Medicine, Baltimore, USA
Link Wolberger Lab

Board of Trustees

The joint Board of Trustees of the Max Planck Institutes of Biochemistry and the MPI for Biological Intelligence is an important instrument for communication between the institutes and the public. The board is composed of influential members of society from politics, business, science and the media. It meets once a year with the management of the institutes and the Max Planck Society to inform itself about developments at the institutes and in the Max Planck Society in general and to advise the institutes on social and science policy issues.

Members

  • Luitpold Prinz von Bayern
    Entrepreneur, König Ludwig International GmbH & Co. KG
  • Prof. Dr. Peter B. Becker
    CEO, LMU Biomedical Center, Planegg-Martinsried
  • Prof. Dr. Francesca Biagini
    Vice President for International Affairs and Diversity, Ludwig-Maximilians University, Munich
  • Prof. Dr. Alena Buyx
    Director, Institute of Ethics in Medicine and Health Technologies, Technical University of Munich
  • Prof. Dr. Marianne Dieterich
    Director, LMU Neurological Clinic, Clinic Großhadern, Ludwig-Maximilians University, Munich
  • Stefan Frey
    Head of Landratsamt Starnberg
  • Christoph Göbel
    Head of Landratsamt Landkreis Munich
  • Prof. Dr. Michael John Gorman
    Founding Director, BIOTOPIA – Naturkundemuseum Bayern e.V..
  • Prof. Dr. Thomas Hofmann
    President, Technical University of Munich, Freising
  • Jonas Kaufmann
    Kammersänger, Munich
  • Hermann Nafziger
    1. Mayor of the Municipality of Planegg, Planegg
  • Werner Reuß
    Head of Programs Insight & Education, Bayerischer Rundfunk, Munich
  • Prof. Dr. Monika Schnitzer
    Director Comparative Economics, Ludwig-Maximilians-University, Munich
  • Dr. Marlene Weiß
    Head of purview „Insight“, Süddeutsche Zeitung GmbH, Munich
  • MDirig Dr. Manfred Wolter
    Head of Department Innovation, Science, Technology, Digitalization, Bavarian State Ministry of Economics, Munich
Representatives of MPIB'S scientific staff in the Biology & Medicine Section

Representatives of MPIB'S scientific staff in the Biology & Medicine Section

The representative of the Institute's scientific staff who is elected for three years attends the meetings of both the Biology & Medicine Section (BMS) and the Scientific Council of the MPG as a voting member and may participate in BMS committees. He is invited to the meetings of the Martinsrieder Kreis (MPI of Biochemistry) and informs the scientific staff about developments at the Institute and within the BMS. Representative of MPIB's scientific staff in the BMS: Dr. Daniel Bollschweiler.


Link Biological and Medical Section of the Max Planck Society
Link Senate of the Max Planck Society
Web-View
Print Page
Open in new window
Estimated DIN-A4 page-width
Go to Editor View